Palbociclib is an oral third-generation targeted therapy drug that is in the CDK4/6 inhibitors group of medication. This is achieved through prevention of the multiplication of such cells which are common with tumors. Most often used in conjunction with other drugs, Palbociclib has contributed to enhancements in the patients’ lives. https://hootmix.com/palbociclib-price-trends-what-patients-should-know-in-2025/